These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17376053

  • 1. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
    Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, Chayama K.
    J Gastroenterol Hepatol; 2007 Apr; 22(4):571-6. PubMed ID: 17376053
    [Abstract] [Full Text] [Related]

  • 2. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan.
    Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K.
    Aliment Pharmacol Ther; 2005 May 01; 21(9):1121-6. PubMed ID: 15854174
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up.
    Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, Egi Y, Kitadai Y, Yasui W, Yoshihara M, Haruma K, Chayama K.
    Aliment Pharmacol Ther; 2005 Mar 01; 21(5):559-66. PubMed ID: 15740539
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication.
    Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K.
    Digestion; 2008 Mar 01; 78(2-3):113-9. PubMed ID: 19023205
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME.
    Ter Arkh; 2006 Mar 01; 78(2):26-31. PubMed ID: 16613092
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep 01; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 15. [Helicobacter pylori eradication therapy does not prevent gastric cancer development in all patients].
    Take S, Ishiki K, Mizuno M.
    Gan To Kagaku Ryoho; 2011 Mar 01; 38(3):353-7. PubMed ID: 21403436
    [Abstract] [Full Text] [Related]

  • 16. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S, Matsukura N, Matsuda N, Tsuchiya S, Naito Z, Tajiri T.
    J Gastroenterol Hepatol; 2008 Dec 01; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [Abstract] [Full Text] [Related]

  • 17. Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Chabannaya TA.
    Rocz Akad Med Bialymst; 2005 Dec 01; 50():183-7. PubMed ID: 16358962
    [Abstract] [Full Text] [Related]

  • 18. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, Russo VM, Tampieri A, Bernabucci V, Miglioli M, Vaira D.
    Am J Gastroenterol; 2004 Oct 01; 99(10):1910-5. PubMed ID: 15447749
    [Abstract] [Full Text] [Related]

  • 19. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J.
    Pol Merkur Lekarski; 2008 Feb 01; 24(140):95-100. PubMed ID: 18634262
    [Abstract] [Full Text] [Related]

  • 20. The non-invasive diagnosis of precancerous changes of stomach mucosa.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Polyakova MB, Mernova VP.
    Rocz Akad Med Bialymst; 2004 Feb 01; 49():66-71. PubMed ID: 15631316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.